Day: September 22, 2025
Yangtze River Pharmaceutical Group Unveils Innovative Anti-insomnia Drug Fazamorexant at World Sleep Congress 2025
TAIZHOU, Jiangsu, Sept. 21, 2025 — Recently, the pivotal Phase III clinical trial results for Fazamorexant, a pioneering new anti-insomnia drug developed in-house by...
Survey shows nearly two-thirds of Germans unhappy with Merz
The new chancellor’s public approval continues its decline amidst a deepening cost-of-living crisis and growing anxieties over migration, according to fresh polling data. German...